NO20020793D0 - Virkestoffkombinasjon med clonidin - Google Patents

Virkestoffkombinasjon med clonidin

Info

Publication number
NO20020793D0
NO20020793D0 NO20020793A NO20020793A NO20020793D0 NO 20020793 D0 NO20020793 D0 NO 20020793D0 NO 20020793 A NO20020793 A NO 20020793A NO 20020793 A NO20020793 A NO 20020793A NO 20020793 D0 NO20020793 D0 NO 20020793D0
Authority
NO
Norway
Prior art keywords
clonidine
active ingredient
ingredient combination
combination
active
Prior art date
Application number
NO20020793A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020793L (no
Inventor
Hans-Michael Brecht
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20020793L publication Critical patent/NO20020793L/no
Publication of NO20020793D0 publication Critical patent/NO20020793D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20020793A 1999-08-19 2002-02-18 Virkestoffkombinasjon med clonidin NO20020793D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19938825A DE19938825A1 (de) 1999-08-19 1999-08-19 Wirkstoffkombination mit Clonidin
PCT/EP2000/007718 WO2001013902A2 (de) 1999-08-19 2000-08-09 Wirkstoffkombination enthaltend clonidin und pramipexol

Publications (2)

Publication Number Publication Date
NO20020793L NO20020793L (no) 2002-02-18
NO20020793D0 true NO20020793D0 (no) 2002-02-18

Family

ID=7918574

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020793A NO20020793D0 (no) 1999-08-19 2002-02-18 Virkestoffkombinasjon med clonidin

Country Status (19)

Country Link
US (1) US20020010201A1 (de)
EP (1) EP1210081A2 (de)
JP (1) JP2003507420A (de)
KR (1) KR20020060163A (de)
AR (1) AR025330A1 (de)
AU (1) AU6440600A (de)
BR (1) BR0013353A (de)
CA (1) CA2376606A1 (de)
CO (1) CO5200840A1 (de)
CZ (1) CZ2002515A3 (de)
DE (1) DE19938825A1 (de)
IL (1) IL147741A0 (de)
MX (1) MXPA02001138A (de)
NO (1) NO20020793D0 (de)
PE (1) PE20010642A1 (de)
PL (1) PL353358A1 (de)
TR (1) TR200200449T2 (de)
UY (1) UY26293A1 (de)
WO (1) WO2001013902A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
MXPA04005572A (es) 2001-12-11 2004-12-06 Univ Virginia Uso de pramipexol para tratamiento de esclerosis lateral amiotrofica.
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
DE10220230A1 (de) * 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
DE60322067D1 (de) 2002-08-30 2008-08-21 Kyowa Hakko Kogyo Kk Adenosin-a2a-rezeptorantagonisten zur behandlung des syndroms der unruhigen beine oder nächtlichen myoklonus
DE60204229T2 (de) * 2002-12-02 2006-02-02 Schwarz Pharma Ag Verabreichung von Rotigotine zur Behandlung der Parkinson'schen Krankheit durch Iontophorese
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
KR20090021169A (ko) 2006-05-16 2009-02-27 크놉 뉴로사이언시스 인코포레이티드 Ｒ(+) 및 ｓ(-) 프라미펙솔을 포함하는 조성물 및 이의 사용 방법
WO2008009664A2 (en) * 2006-07-19 2008-01-24 Boehringer Ingelheim International Gmbh Treatment of pain
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
CN101715443A (zh) 2007-03-14 2010-05-26 诺普神经科学股份有限公司 手性纯化的取代的苯并噻唑二胺的合成
EP1987815A1 (de) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Im Mund-Nasen-Rachenraum verabreichbare pharmazeutische Zusammensetzungen enthaltend Dopaminagonisten zur Vorbeugung und/oder Behandlung von unruhigen Gliedmassen
US20110190356A1 (en) 2008-08-19 2011-08-04 Knopp Neurosciences Inc. Compositions and Methods of Using (R)- Pramipexole
WO2013096816A1 (en) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
WO2014105783A1 (en) * 2012-12-28 2014-07-03 Noven Pharmaceuticals, Inc. Compositions and methods for transdermal delivery of amphetamine and clonidine
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
ES3043076T3 (en) 2013-07-12 2025-11-24 Areteia Therapeutics Inc Treating elevated levels of eosinophils and/or basophils
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
ES2871556T3 (es) 2013-08-13 2021-10-29 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de la urticaria crónica
WO2015023786A1 (en) 2013-08-13 2015-02-19 Knopp Biosciences Llc Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
DE4325491A1 (de) * 1993-07-29 1995-02-02 Boehringer Ingelheim Kg Verwendung von zentral wirksamen alpha-2-Agonisten zur Hemmung des Postaggressionsstoffwechsels
DE19701619B4 (de) * 1997-01-17 2007-10-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Pramipexol zur Behandlung des restless legs syndroms
US6001861A (en) * 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
WO2000054773A1 (en) * 1999-03-12 2000-09-21 Nitromed, Inc. Dopamine agonists in combination with nitric oxide donors, compositions and methods of use

Also Published As

Publication number Publication date
JP2003507420A (ja) 2003-02-25
EP1210081A2 (de) 2002-06-05
AR025330A1 (es) 2002-11-20
TR200200449T2 (tr) 2002-08-21
IL147741A0 (en) 2002-08-14
CO5200840A1 (es) 2002-09-27
CZ2002515A3 (cs) 2002-05-15
PL353358A1 (en) 2003-11-17
NO20020793L (no) 2002-02-18
PE20010642A1 (es) 2001-06-08
UY26293A1 (es) 2001-04-30
CA2376606A1 (en) 2001-03-01
WO2001013902A2 (de) 2001-03-01
WO2001013902A3 (de) 2001-08-23
DE19938825A1 (de) 2001-04-26
BR0013353A (pt) 2002-04-23
AU6440600A (en) 2001-03-19
US20020010201A1 (en) 2002-01-24
MXPA02001138A (es) 2002-10-31
KR20020060163A (ko) 2002-07-16

Similar Documents

Publication Publication Date Title
PT1220856E (pt) Compostos farmaceuticamente activos
ATE243933T1 (de) Fungizide wirkstoffkombinationen
EE200000438A (et) Farmatseutiliselt aktiivne morfolinool
ID26056A (id) Popok sekali pakai
ID26389A (id) Popok sekali pakai
NL350038I1 (nl) Herbicidaal actieve 3-hydroxy-4-aryl-5-oxopyrazoline derivaten
ATE392890T1 (de) Hydrogel-gesteuerte dosierungsform
ATE259798T1 (de) Pharmazeutisch aktive verbindungen
ATE241272T1 (de) Herbizide zusammensetzung
PT1060695E (pt) Cadeira empilhavel
DK1168916T3 (da) Landbrugskemikalieformuleringer
EE200200150A (et) Preparaat
ID25571A (id) Popok sekali pakai
ID24782A (id) Popok sekali pakai
DE60029393D1 (de) Bolzen
ATE240642T1 (de) Agrochemische zusammensetzung
ATE276659T1 (de) Fungizide wirkstoffkombinationen
DE59902159D1 (de) Aktiver mikromischer
ATE239375T1 (de) Fungizide wirkstoffkombinationen
DE60019505D1 (de) Mikrobizide Wirksubstanzen
DE60034215D1 (de) Oberflaechenaktive zusammensetzung
FI19992468L (fi) Tuoli
DE60013371D1 (de) Verriegelungsvorrichtung
DE60004561D1 (de) Aktive baugruppe
SE9901854D0 (sv) New pharmaceutically active compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application